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EDITORIAL
Predictors  of dengue  severity,
Preditores  de  gravidade  da  dengue
Scott B. Halsteadeven
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‘Uniformed  University  of  the  Health  Sciences,  Department  of  Pr
Pone  et  al.,  in  a  study  published  in  this  Journal,  have
attempted  to  identify  historical  or  observable  signs  or  symp-
toms  that  reliably  predict  worsening  of  dengue  disease  in
children.1 In  so  doing,  they  have  coined  a  new  term  ‘‘serious
dengue  disease’’  and  adopted  a  new  clinical  outcome
metric,  ‘‘treatment  modality.’’  The  ‘‘treatment  modali-
ties’’  chosen  include  administration  of  ‘‘amines,  inotropes,
colloids,  mechanical  ventilation,  non-invasive  ventilation,
peritoneal  dialysis  or  hemodialysis.’’  Lethargy,  abdominal
distension,  pleural  effusion,  and  hypoalbuminemia  were  the
most  reliable  markers  of  serious  dengue  disease  identiﬁed
in  145  children  hospitalized  in  Rio  de  Janeiro  in  2007--2008,
who  had  direct  or  indirect  evidence  of  recent  dengue  infec-
tion.  The  authors  are  among  those  who  would  agree  that
a  more  accurate  identiﬁcation  of  dengue  predictors  would
best  be  derived  from  large  protocol-based  prospective  stud-
ies  of  physiologically  characterized  laboratory  conﬁrmed
dengue  illnesses.
There  is  considerable  historical  precedent  for  this
effort.  Ever  since  the  1950s,  when  it  was  recognized  that
dengue  viruses  caused  a  severe  and  often  fatal  acute  febrile
disease  of  children,  it  has  been  the  goal  of  researchers  to
describe  the  pathophysiology  of  dengue  disease  aiming  to
provide  better  treatment  and  to  identify  predictive  early
warning  markers  to  improve  triage.2,3 This  was  the  moti-
vation  behind  the  creation  of  the  case  deﬁnitions,  dengue
hemorrhagic  fever/dengue  shock  syndrome  (DHF/DSS),  in
wide  use  since  their  adoption  by  WHO  in  1975,  and  the
new  case  deﬁnitions  introduced  in  2009.4,5 In  the  1960s,
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engue  research  programs  in  Southeast  Asia  found  that
hildren  were  dying  of  a  new  clinical  entity,  the  dengue
ascular  permeability  syndrome  (DVPS;  Fig.  1),  character-
zed  by  a  complex  of  physiologic  abnormalities  affecting
ultiple  organ  systems  including  the  liver,  blood  coagu-
ation,  complement,  hematopoiesis,  serum  proteins,  and
he  vascular  system  that  reach  a  maximal  expression
t  defervescence.3,6--10 It  soon  was  well  understood  that
hildren  with  DVPS  beneﬁtted  from  early,  physiologically
elevant  ﬂuid  resuscitation.6 It  was  also  observed  that  the
uid  leak  varied  in  severity  from  child  to  child  and  that
 physiologically  irreversible  penalty  might  occur  in  just  a
atter  of  hours  due  to  failure  to  maintain  adequate  blood
olume.5,11--13
The  signs  and  symptoms  of  dengue  and  DVPS  change  from
ay  to  day.  Those  that  precede  shock  have  been  identiﬁed  as
‘warning  signs.’’  Warning  signs  of  dengue  infections  were
escribed  long  ago.  Siler  and  Simmons,  who  recorded  daily
linical  and  laboratory  features  of  several  hundred  experi-
ental  dengue  illnesses  mostly  in  seronegative  young  adult
ale  US  Army  volunteers,  observed  a profound  mid-illness
engue  leukopenia.14,15 More  importantly,  they  found  this
eukopenia  consisted  of  two  components,  a  reduction  in
irculating  lymphocytes  and  a  destruction  of  mature  poly-
orphonuclear  leukocytes.  The  latter  produced  a  diagnostic
‘cross,’’  where  there  were  greater  numbers  of  immature
han  mature  polys  in  blood  smears.15 It  has  been  speculated
hat  leukopenia  and  thrombocytopenia  might  be  related  to
 remarkable  phenomenon  that  regularly  occurs  in  dengue
nfections  before  the  onset  of  fever,  a  profound  suppression
f  all  cellular  elements  in  the  bone  marrow.16,17 In  Thailand,
hree  early  warning  signs  were  used  in  patient  triage:  throm-
ocytopenia  and  a  positive  tourniquet  test  were  thought
o  herald  dengue  vascular  permeability,  while  a ﬁngertip
icrohematocrit  was  taken  to  establish  a  baseline  value
dade Brasileira de Pediatria. This is an open access article under
d/4.0/).
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Dengue vascular permeability syndrome (DVPS)
• A syndrome that occurs late in the course of an acute dengue illness (on or near
defervescence), consisting of:
    –    Thrombocytopenia (< 100 000/mm3)
    –    Altered hemostasis: most commonly prolonged bleeding time, elevated
          activated partial thromboplastin time, and/or reduced fibrinogen levels.
    –    Activated complement, by classical and alternative pathways.
    –    Elevated liver transaminase enzyme levels usually accompanied by enlarged
          liver.
    –    Vascular permeability with clinically significant loss of fluid and small
         macromolecules (e.g., hypoalbuminemia) into interstitial spaces, commonly
         serosal cavities.
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2Figure  1  Dengue  vascular  permeability  syndrome  (DVPS).
o  monitor  hemoconcentration.18 Because  platelet  numbers
ecline  and  hematocrits  rise  quickly,  multiple  measure-
ents  must  be  performed  and  disease  severity  eventually  is
ost  accurately  scored  using  modal  high  or  low  values.  Some
orkers  found  that  high  levels  of  aspartate  aminotransferase
dentiﬁed  those  children  who  proceeded  to  DVPS.18 Careful
hysiological  characterization  of  dengue  illnesses  in  children
as  resulted  in  signiﬁcant  improvement  in  treatment  and
harply  reduced  case  fatality  rates.11,19
There  has  been  considerable  disagreement  about  the
tility  of  most  warning  signs  or  laboratory  tests  in  wide
se  for  predicting  the  outcome  of  dengue  infections.20 One
pproach  to  identify  predictors  has  been  to  look  for  universal
omponents  in  DSS.  A  meta-analysis  identiﬁed  the  signiﬁ-
ant  associations  of  shock  as  age,  female  sex,  neurological
igns,  nausea/vomiting,  abdominal  pain,  gastrointestinal
leeding,  hemoconcentration,  ascites,  pleural  effusion,
ypoalbuminemia,  hypoproteinemia,  hepatomegaly,  levels
f  alanine  transaminase  and  aspartate  transaminase,  throm-
ocytopenia,  prothrombin  time,  activated  partial  thrombo-
lastin  time,  ﬁbrinogen  level,  primary/secondary  infection,
nd  DENV-2.21 The  vast  expansion  of  dengue  infection  glob-
lly  has  placed  great  stress  on  clinical  facilities,  generating
urther  efforts  to  improve  patient  triage  by  validating
arly  warning  signs.22--25 One  such  study  will  enroll  7000--
000  children  with  a  febrile  disease  who  are  admitted
o  outpatient  departments  in  eight  dengue-endemic
ountries.22 This  large  prospective  study,  now  in  progress,
ncludes  three  sites  in  Brazil.  As  of  December  2015,  a
otal  of  7096  participants  had  been  enrolled,  with  dengue
onﬁrmed  in  2510/5996  (42%).  Enrolment  will  continue
ntil  June  2016.  It  is  hoped  that  sufﬁcient  numbers  of
hildren  with  acute  dengue  infections  will  proceed  on  to
evere  dengue,  providing  unequivocal  laboratory  or  clinical
redictors,  speciﬁcally  for  DSS.
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